Dewani killer treated for rare tumour   / 26 Nov '12, 12:55am
Cape Town - Anni Dewani's killer suffers from an extremely rare
brain cancer with a low survival rate, the Western Cape High
Court heard on Monday.   Jeanette Parkes, an oncologist at
Groote Schuur hospital, said Xolile Mngeni was diagnosed with a
pineoblastoma in May last year and underwent surgery two months
later.  Xolile Mngeni, who was found guilty for the slaying of
Anni Dewani sits in the dock of a courtroom in Cape Town.
Credit: AP   “It's a very rare kind of brain tumour. It
represents less than 0.1 percent of brain tumours,” she told the
court.   “It's more common in children and disseminates in the
brain. It causes seeding in the brain and around the spinal
cord.”   She said international studies showed there was a less
than 20 percent chance of survival over a five-year period.
 Parkes was testifying in mitigation of sentence. Mngeni was
convicted of the premeditated murder of the tourist last week.
 He was also found guilty of robbe